News

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
MedPage Today on MSN18h
FDA Panel Recommends Monovalent COVID Vaccine for Next Season
An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...
FDA offers new guidelines to shift COVID vaccine focus to high-risk groups
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...
Mass. residents say they're not worried by new COVID vaccine guidelines
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...
Trump's FDA Has Axed COVID Boosters For Most People — And Medical Experts Are Deeply Worried
The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...
Federal Officials May Limit Recommendations for Covid Vaccine
With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.
FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
CIDRAP22h
Vaccine Integrity Project says new FDA rules on COVID-19 vaccines show lack of consensus, clarity
Yesterday the Vaccine Integrity Project (VIP), a panel of leading public health and policy experts, published a viewpoint on ...